The U.S. Environmental Protection Agency (EPA) has extended its Emerging Viral Pathogen (EVP) Guidance for Antimicrobial Pesticides (Guidance) in response to the mpox virus (formerly monkeypox), which had been considered to be a rare disease caused by infection with the mpox virus. EPA developed its Guidance in 2016 to address emerging pathogens. Under this Guidance, EPA provides pesticide registrants with a voluntary “two-stage process to enable use of certain EPA-registered disinfectant...
Archives
The U.S. Environmental Protection Agency (EPA) has activated its Emerging Viral Pathogen (EVP) Guidance for Antimicrobial Pesticides (Guidance) in response to hantavirus, which had been considered to be a rare disease caused by an infection from some hantaviruses (including Andes Virus). According to the U.S. Centers for Disease Control and Prevention (CDC), hantaviruses are a family of viruses that cause serious illness and sometimes death in people worldwide. The viruses are spread by infected...
October 26, 2021
EPA Announces Revisions to Guidance to Ensure Effectiveness of Antimicrobial Pesticides against Candida auris
On October 15, 2021, the U.S. Environmental Protection Agency (EPA) announced that it has revised its guidance for evaluating the efficacy of antimicrobial pesticides against Candida auris (C. auris). EPA states that pesticide manufacturers seeking to register their products with a C. auris claim should use this updated guidance to test the effectiveness of the products against a drug-resistant strain of C. auris. EPA states that C. auris is an...
January 29, 2021
Registration Opens for First Committee Meeting on Guidance on PFAS Testing and Health Outcomes
On February 4, 2021, the ad hoc committee appointed by the National Academies of Sciences, Engineering, and Medicine (the National Academies) to consider current evidence regarding human health effects of the most widely studied per- and polyfluoroalkyl substances (PFAS) will hold its first meeting. The National Academies will provide the Centers for Disease Control and Prevention (CDC), the Agency for Toxic Substances and Disease Registry (ATSDR), and the National...
On November 4, 2020, the U.S. Environmental Protection Agency (EPA) published a notice in the Federal Register announcing the release of an updated list of pests of significant health importance for public review and comment. 85 Fed. Reg. 70146. EPA, in coordination with the Centers for Disease Control and Prevention (CDC) and the U.S. Department of Agriculture (USDA), identifies pests of significant public health importance, and in coordination with the Public Health Service,...
On June 30, 2020, from 9:00 a.m.-10:30 a.m. (EDT), the European Union (EU) NanoSafety Cluster will hold a webinar on “Immune response from occupational exposure to CNTs and nanofibres.” The following speakers will discuss work at the U.S. Centers for Disease Control and Prevention (CDC) National Institute for Occupational Safety and Health (NIOSH) on the association of occupational exposure with ex vivo functional immune response in workers handling carbon nanotubes and...
On April 29, 2020, the U.S. Environmental Protection Agency (EPA) and the Centers for Disease Control and Prevention (CDC) released updated guidance to give assistance to facility operators and families on how to clean and disinfect spaces properly. Developed in cooperation with the White House, the updated guidance provides step-by-step instructions for public spaces, workplaces, businesses, schools, and homes, and falls in line with the Opening up America Again guidelines, the...
February 20, 2020
EPA Registers New Uses for Existing Products to Help Reduce the Spread of Candida auris
On February 12, 2020, the U.S. Environmental Protection Agency (EPA) announced the availability of 11 products that have been approved for use to disinfect surfaces against the emerging multidrug-resistant fungus Candida auris (C. auris). C. auris can cause severe infections and spreads easily among hospitalized patients and nursing home residents. The 11 products are approved for use against C. auris to disinfect surfaces in hospitals, nursing homes, and other healthcare facilities,...
September 12, 2019
CDC Seeks Additional Comment on Proposed NIOSH Project That Will Survey Engineered Nanomaterial Occupational Safety and Health Practices
The Centers for Disease Control and Prevention (CDC) published a Federal Register notice on September 11, 2019, to provide an additional 30-day comment period on its proposed information collection project entitled “Survey of Engineered Nanomaterial Occupational Safety and Health Practices.” 84 Fed. Reg. 47957. As reported in our April 24, 2019, blog item, on April 23, 2019, CDC published a Federal Register notice inviting comment on the proposed...
February 17, 2017
CDC Issues New Guidance For Use of EPA-Registered Disifectants in Environmental Control of Candida auris for U.S. Healthcare Facilities
On February 17, 2017, the U.S. Environmental Protection Agency (EPA) announced that the Centers for Disease Control and Prevention (CDC) issued guidance revising its recommendation regarding controlling Candida auris (C. auris) infections in U.S. healthcare facilities. The CDC guidance now recommends a “thorough daily and terminal cleaning and disinfection” of patient rooms in which C. auris infection or colonization was present … with the use of an...